Overcoming Challenges of Batch Manufacturing with Fully Connected Continuous Manufacturing

This presentation features Sundar Ramanan, chief quality officer, Enzene Biosciences, who talks about how high capital costs render fed-batch production impractical for small, emerging biotechnology companies needing to expedite molecule development. And many people around the world have limited access to biologics. Ramanan said that such concerns could be addressed by adopting technologies for FCCM.

Register or Login and hit Watch on Demand to view the recorded webcast now.